Bronchoscopy: Steps and Advanced Techniques
Bronchoscopy is performed through systematic visualization of the airways, with specialized techniques like EBUS primarily used for mediastinal/hilar lymph node sampling (requiring ≥4 needle passes for optimal yield), while cryotherapy serves dual roles in both tissue destruction for airway obstruction and high-quality tissue acquisition for diagnosis.
Standard Bronchoscopy Steps
Basic Procedure Framework
- Airway access: Via oral or nasal route using flexible or rigid bronchoscope
- Systematic inspection: Sequential examination of trachea, main bronchi, lobar and segmental airways
- Targeted intervention: Based on clinical indication (diagnostic sampling, therapeutic intervention, or both)
- Post-procedure monitoring: For complications including bleeding, pneumothorax, or respiratory compromise
EBUS (Endobronchial Ultrasound)
Primary Clinical Applications
EBUS-TBNA has become the gold standard for lung cancer diagnosis and staging of mediastinal and hilar lesions 1, 2. The technique provides real-time ultrasound guidance for needle aspiration of lymph nodes and masses adjacent to the airways.
Technical Specifications for Optimal Yield
For malignant disease 1:
- Needle size: Use 21-gauge or 22-gauge needles (smaller preferred over 19-gauge)
- Number of passes: Perform ≥4 needle passes (strong recommendation despite very low certainty evidence)
- Specimen handling: Either standard alcohol-based preparations OR alternative media (formalin, RPMI, saline, PBS) are acceptable
- ROSE (Rapid On-Site Evaluation): Suggested over usual care when available
For nonmalignant disease 1:
- Needle size: Either 21/22-gauge OR 19-gauge acceptable (more flexibility than malignant cases)
- Number of passes: ≥4 passes recommended
- Collection media: Same flexibility as malignant disease
- ROSE: Suggested when available
EBUS-Guided Cryobiopsy: Emerging Technique
EBUS-cryobiopsy provides larger, higher-quality specimens with minimal crush artifact compared to standard EBUS-TBNA 3, 4. This is particularly valuable when:
- Diagnosing lymphoproliferative disorders requiring intact tissue architecture
- Molecular pathology analysis needed for advanced NSCLC
- EBUS-TBNA has diagnostic limitations (sarcoidosis, silicosis, rare metastases)
Standardized four-step approach 4:
- Create access pathway (via high-frequency needle knife incision or needle tract)
- Insert cryoprobe under ultrasound guidance
- Freeze-thaw cycle for tissue adherence
- Extract specimen with preserved architecture
For centrally located intrapulmonary lesions, EBUS-cryo through EBUS-TBNA tract achieves 95.7% diagnostic yield with 72.8% high-quality specimen retrieval rate, though moderate bleeding occurs in 5.7% of cases 5.
Cryotherapy Applications
Mechanism and Equipment
Cryotherapy uses rapid freeze-thaw cycles causing cell death, tissue necrosis, or tissue adherence 6. Delivered via:
- Cryoprobe: Through flexible/rigid bronchoscope working channel
- Spray cryotherapy: Direct application
Clinical Uses
1. Central Airway Obstruction (CAO) 7, 6:
- Malignant CAO: Local cryotherapy recommended as personalized approach to reduce recurrence and prolong time to reintervention
- Nonmalignant CAO: Part of multimodal approach including dilation, steroid injection, mitomycin C application
- Mechanism: Tumor debulking through tissue necrosis
2. Diagnostic Cryoadhesion 6:
- Endobronchial biopsies: Controlled data support use, though increased risk of controllable bleeding
- Transbronchial biopsies: Active investigation area with limited controlled data
- Advantage: Larger specimens with preserved architecture vs. forceps biopsy
3. Foreign Body Removal 6:
- Cryoadhesion allows extraction of foreign bodies through tissue freezing and adherence
4. Low-Grade Airway Malignancy 6, 8:
- Local treatment option for early-stage endobronchial lesions
- May avoid or delay need for stent placement 7
Integration with Other Therapies
Cryotherapy can be combined with 7, 6:
- Photodynamic therapy (PDT): Though PDT alone showed mean time to reintervention of 147 vs 98 days (non-significant)
- Brachytherapy: For local disease control
- Radiation: Promising synergy under investigation
Surveillance and Follow-up
For patients with stent placement: Routine surveillance bronchoscopy within 3 months does NOT detect complications unless patients are symptomatic 7. Therefore:
- Symptom-driven bronchoscopy is preferred over routine surveillance
- Use chest CT scans for stent/airway patency assessment
- Implement mucociliary clearance interventions (hypertonic saline nebulization)
Critical Pitfalls to Avoid
- Inadequate EBUS sampling: Fewer than 4 needle passes significantly reduces diagnostic yield 1
- Wrong needle size selection: 19-gauge needles less optimal for malignant disease 1
- Routine surveillance bronchoscopy post-stent: Wastes resources; 84% of complications occur in symptomatic patients anyway 7
- Cryobiopsy bleeding: Expect moderate bleeding in ~6% of cases; ensure hemostasis capability 5
- Specimen handling errors: Coordinate with pathology regarding collection media based on suspected diagnosis 1